Skin test reactivity to recombinant Aspergillus fumigatus allergen I/a in patients with cystic fibrosis

International Archives of Allergy and Immunology
W H NikolaizikM H Schöni

Abstract

We evaluated the diagnostic value of recombinant Aspergillus fumigatus allergen I/a (rAsp f I/a) for skin testing in cystic fibrosis (CF) patients with allergic bronchopulmonary aspergillosis (ABPA), allergy to A. fumigatus and in CF controls not allergic to A. fumigatus. Skin prick test reactions to rAsp f I/a were 8.5-fold stronger in A.-fumigatus-allergic and 3.3-fold stronger in ABPA patients compared to the CF controls. Three out of 6 well-characterized ABPA patients had positive skin prick test reactions to rAsp f I/a; the same number reacted to crude A. fumigatus extracts. The skin prick test results to rAsp f I/a were significantly correlated with those to crude and commercial preparations. According to these results, rAsp f I/a represents a defined allergen that provides the possibility to perform skin prick tests in CF patients in a highly standardized way. In future, a larger panel of recombinant allergens might also pick up those CF patients with ABPA and allergy to A. fumigatus who did not react to this single allergen.

Citations

Aug 28, 1998·Research in Immunology·V P KurupP S Murali
Dec 16, 1997·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·B C Hilman
Dec 31, 1997·American Journal of Respiratory and Critical Care Medicine·S HemmannR Crameri
Apr 6, 2002·American Journal of Respiratory and Critical Care Medicine·Wilfried H NikolaizikReto Crameri
Sep 9, 2006·American Journal of Respiratory and Critical Care Medicine·Richard KraemerReto Crameri
Mar 21, 2009·Expert Review of Molecular Diagnostics·Gaudenz M HafenPhilipp Latzin
Jul 17, 2015·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·V N Maturu, R Agarwal
Aug 8, 2013·Methods : a Companion to Methods in Enzymology·Verena NiederbergerGabrielle Pauli
Apr 30, 2016·Allergy, Asthma & Immunology Research·Ashok Shah, Chandramani Panjabi
Aug 28, 1998·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·S HemmannR Crameri
Jun 10, 2000·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·V P KurupR Crameri
Jun 22, 2018·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Valliappan MuthuRitesh Agarwal
Apr 28, 2005·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Carmen CasaultaMartin H Schoeni
Nov 30, 2013·Allergy·R CrameriC Huitema
Aug 26, 1998·Mycoses·R CrameriK Blaser

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.